e-learning
resources
Munich 2014
Monday, 08.09.2014
Non inflammatory monitoring of airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effect of different symptom and risk assessments in classifying pulmonary rehabilitation patients according to the new GOLD guidelines
C. de Jong, M. Wittmann, D. Jelusic, M. Schuler, H. Alma, T. van der Molen, K. Schultz (Groningen, Netherlands; Bad Reichenhall, Würzburg, Germany)
Source:
International Congress 2014 – Non inflammatory monitoring of airway diseases
Session:
Non inflammatory monitoring of airway diseases
Session type:
Poster Discussion
Number:
3011
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. de Jong, M. Wittmann, D. Jelusic, M. Schuler, H. Alma, T. van der Molen, K. Schultz (Groningen, Netherlands; Bad Reichenhall, Würzburg, Germany). The effect of different symptom and risk assessments in classifying pulmonary rehabilitation patients according to the new GOLD guidelines. Eur Respir J 2014; 44: Suppl. 58, 3011
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Related content which might interest you:
GOLD assessment of COPD patients: Impact of symptoms assessment choice
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012
New GOLD recommendations in a seven years follow up - changes in symptoms and risk categories
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013
Characterization of patients with COPD GOLD stage I and II referred for pulmonary rehabilitation
Source: International Congress 2015 – Latest insights into chronic care
Year: 2015
Comparison of CAT and mMRC in evaluating clinical symptoms co-morbidity and medical resource utilization in COPD patients
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Responsiveness of the clinical COPD questionaire to pulmonary rehabilitation
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013
COPD comorbidities and risk assessment according to GOLD 2011 revision
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
Assessment of patients with COPD according to previous and new GOLD: Which stage in which group?
Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care
Year: 2014
Physician attitudes toward questionnaires and indices for COPD.Results of On-Sint study
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014
Health status in the GOLD guidelines era. Assessing the new COPD severity staging criteria
Source: Eur Respir J 2002; 20: Suppl. 38, 251s
Year: 2002
Disease progression and changes in risk groups' classification over a period of one year in the GPs based Swiss chronic obstructive pulmonary disease (COPD) cohort
Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care
Year: 2014
Effectiveness of a 3-week-in-patient-rehabilitation-program in patients with COPD GOLD-stage IV
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 1)
Year: 2013
The association between objective CT measures of bronchiectasis and health-related quality of life in COPD
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014
Discordant symptom severity in COPD: The PHAROAH study
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015
Measurement of COPD’s impact using the COPD assessment test (CAT) and symptom assessment differences between patients and family members
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
Predictive role of mMRC scale on quality of life in COPD patients
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2)
Year: 2013
Development of the Manchester early morning symptoms index in COPD
Source: International Congress 2014 – COPD physiopathology
Year: 2014
The frequency of exacerbations in COPD patients and its influence on the effects of pulmonary rehabilitation
Source: International Congress 2014 – Latest insights in chronic care
Year: 2014
Implementation of COPD phenotypes in real life
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
Does the effectiveness of pulmonary rehabilitation vary in patients with different baseline severity of symptoms classified by MRC grade?
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2)
Year: 2013
Response of the COPD assessment test (CAT) to short-term inpatient pulmonary rehabilitation
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept